Key result
Carotid-body tumors have a malignant potential of approximately 15%, complicating their management which historically carried a prohibitive operative mortality of 40% to 55%.
Population
Patients with carotid-body tumors
Design
Review
Authors
Loading...
Requires weighing 15% malignancy risk against operative hazards; leaves open whether modern techniques justify routine resection.
Carotid-body tumors have a malignant potential of approximately 15%, complicating the historical debate between surgical extirpation and conservative management due to high past operative mortality.
J. J. CONLEY (1956) conducted a review in Carotid-body tumor. Carotid-body tumors have a malignant potential of approximately 15%, complicating their management which historically carried a prohibitive operative mortality of 40% to 55%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: